Table 3 Practice Specific Guideline Question Examples
From: Sex and gender specific health topics in medical student learners: pulse check eight years later
Sex and gender-specific items related to practice guidelines (correct answers are noted) | Percentage of students selecting each answer | |||
|---|---|---|---|---|
Present survey | 2012 Survey (4th year students; 2nd year students) | 2012 aggregate survey results (%) | P-value | |
Practice guidelines are often developed based on results of clinical trials. Analyzing clinical studies by sex can include: (select multiple) (all are correct) | ||||
a. Reporting the sex of study subjects | 83.2% | 34.4%; 26.3% | 30.0 | < .001 |
b. Incorporating sex in multivariant analyses | 92.1% | 50.0%; 36.8% | 42.9 | |
c. Analyzing results by sex | 94.1% | 75.0%; 47.4% | 60.0 | |
d. Reporting null findings | 69.3% | 21.9%; 0.0% | 10.0 | |
Differences in fat distribution between men and women affect circulating concentrations of pharmacological therapy | .440 | |||
TRUE (correct) | 94.1% | 84.8%; 94.6% | 90.0 | |
FALSE | 5.9% | 15.2%; 2.7% | 8.6 | |
Don't Know | Not included | 0%; 2.7% | 1.4 | |
In general, current prevention and treatment management strategies take into consideration biological differences between men and women | .111 | |||
TRUE | 18.8% | 25.8%; 31.6% | 29.0 | |
FALSE (correct) | 81.2% | 74.2%; 65.8% | 69.6 | |
Don't Know | Not included | 0%; 2.6% | 1.4 | |
The Cochrane Database has as much evidence about treatment outcomes for women as for men | .162 | |||
TRUE | 6.0% | 7.1%;10.56% | 9.1 | |
FALSE (correct) | 94.0% | 92.9%; 84.2% | 87.9 | |
Don't Know | Not included | 0%; 5.3% | 3.0 | |